Muscarinic toxins: Novel pharmacological tools for the muscarinic cholinergic system

Toxicon

Volumn 38, Issue 6, 2000, Pages 747-761

  Jerusalinsky, D ^a   Kornisiuk, E ^a   Alfaro, P ^a   Quillfeldt, J ^b   Ferreira, A ^a   Rial, Verde E ^a   Duran R ^c   Cervenansky C ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE; SNAKE VENOM; TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AVOIDANCE BEHAVIOR; BINDING AFFINITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HABITUATION; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW;

ANIMALS; BRAIN; ELAPID VENOMS; HUMANS; INJECTIONS, INTRAVENTRICULAR; RECEPTORS, MUSCARINIC; TOXINS, BIOLOGICAL;

ANIMALIA; DENDROASPIS ANGUSTICEPS; MAMMALIA; SERPENTES;

EID: 0033964813     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00196-8     Document Type: Review

References (59)

1. Adem A., Asblom A., Johansson G., Mbugua P.M., Karlsson E. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochem Biophys Acta. 968:1988;340-345.
2. Adem A., Karlsson E. Muscarinic receptor subtype selective toxins. Life Sci. 60:1997;1069-1076.
3. Bonner T., Buckley N., Young A., Brann M. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-532.
4. Boulay S., Sood V., Rayeq M., Cohen V., Zeeberg B., Reba R. Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype. Neuroimage. 3:1996;35-39.
5. Bradley K., Harvey A., Rowan G. Use of muscarinic toxins, MTx1 and MTx3, in the study of synaptic transmission in the peripheral nervous system. Life Sciences. 60:1997;1207.
6. Caulfield M. Muscarinic receptors. Characterization, coupling and function. Pharmacol Ther. 58:1993;319-379.
7. Cortés R., Palacios J. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res. 362:1986;227-238.
8. Dale H. The action of certain esters and ethers of choline, and their relation to muscarine. J Pharmacol Exp Ther. 6:1914;146-190.
9. Dörje F., Levey A., Brann M. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol. 40:1991;459-462.
10. Ducancel F., Rowan E., Cassar E., Harvey A., Ménez A., Boulain J. Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon. 29:1991;516-520.
11. Frey K., Howland M. Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: distinction of receptor subtypes in antagonist competition assays. J Pharmacol Exp Ther. 263:1992;1391-1400.
12. Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 31:1982;2991-2998.
13. Harvey A., Karlsson E. Dendrotoxin from the venom of the Green Mamba, Dendroaspis angusticeps. Naunyn-Schmiedeberg's Arch Pharmacol. 312:1980;1-6.
14. Harvey A., Karlsson E. Polypeptide neurotoxins from mamba venoms that facilitate transmitter release. Trends Pharmacol Sci. 5:1984;71-72.
15. Harvey, A., Kornisiuk, E., Bradley, K., Alfaro, P., Cerveńansky, C., Durán, R., Jerusalinsky, D., 1999. Effects on muscarinic toxins MT1 and MT2 from green mamba venom on tissues containing different subtypes of muscarinic cholinoceptors. Submitted.
16. Hulme E., Birdsall N., Buckley N. Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol. 30:1990;633-673.
17. Hulme E., Kurtenbach E., Curtis C. Muscarinic acetylcholine receptors: structure and function. Biochem Soc Transactions. 19:1991;133-138.
18. Hulme E., Curtis C., Page K., Jones P. Agonist activation of muscarinic acetylcholine receptors. Cellular Signalling. 5:1995;687-694.
19. Izquierdo I. Mechamism of the amnestic action of scopolamine. Trends Pharmacol Sci. 12:1989;128-129.
20. Izquierdo I., Da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B., Medina J. Neurotransmitter receptors involved in memory processing by the amygdala, medial septum and hippocampus of rats. Behavioral and Neural Biology. 58:1992;16-26.
21. Jerusalinsky D., Cerveñansky C., De Robertis E., Dajas F. Two new peptides from Dendroaspis angusticeps venom: are they muscarinic cholinergic toxins? J Neurochem. 52:(Suppl.):1989;S92B.
22. Jerusalinsky D., Cerveñansky C., Peña C., Raskovsky S., Dajas F. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands. Neurochem Int. 20:1992;237-246.
23. Jerusalinsky D., Cerveñansky C., Walz R., Bianchin M., Izquierdo I. A peptide muscarinic toxin from the Green Mamba venom shows agonist-like actions in an inhibitory avoidance learning task. Eur J Pharmacol. 240:1993;103-105.
24. Jerusalinsky D., Harvey A. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends in Phar Sci. 15:1994;424-430.
25. Jerusalinsky D., Kornisiuk E., Bernabeu R., Izquierdo I., Cerveñansky C. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions. Toxicon. 33:1995;389-397.
26. Jerusalinsky D., Kornisiuk E., Izquierdo I. Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochemical Res. 22:1997;507-515.
27. Jerusalinsky D., Raskovsky S., Kornisiuk E., Bernabeu R., Cerveñansky C. Muscarinic toxins from the venom of elapid snakes. Tipton K., Dajas F. Neurotoxins as Tools in Neurobiology. 1994;89-102 Ellis Horwood Ltd, West Sussex.
28. Jerusalinsky D., Harvey A., Karlsson E., Potter L. The use of muscarinic toxins in the study of muscarinic receptors. Life Sciences. 60:1997;1161-1162.
29. Jerusalinsky D., Kornisiuk E., Alfaro P., Quillfeldt J., Alonso M., Rial Verde E., Cerveńansky C., Harvey A. Muscarinic toxin selective for m4 receptors impairs memory in the rat. Neuro Report. 9:1998;1407-1411.
30. Jolkkonen M., Toomela T., Rinken A., Satyapan N., Jarv J., Adem A., Karlsson E. Muscarinic toxins from mamba venoms. Toxicon. 31:1993;524.
31. Jolkonnen M., Adem A., Hellman U., Wernstedt C., Karlsson E. A snake toxin against muscarinic acetylcholine receptors: amino acid sequence, subtype specificity and effect on guinea-pig ileum. Toxicon. 33:1995;399-410.
32. Jolkonnen, M., 1996. Muscarinic toxin from Dendroaspis (mamba) venom. Comprehensive summaries of Uppsala dissertations from the faculty of Science and Technology 183, Acta Universitatis Upsaliensis, Uppsala, Sweden.
33. Jones S., Levey A., Weiner D., Ellis J., Novotny E., Yu S., Dörje F., Wess J., Brann M. Muscarinic acetylcholine receptors. Brann M. Molecular Biology of G-protein Coupled Receptors. 1992;170-197 Birkhauser Ltd, Boston.
34. Karlsson E., Risinger C., Jolkkonen M., Wernstedt C., Adem A. Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon. 29:1991;521-526.
35. Kornisiuk E., Cerveñansky C., Alfaro P., Bassarsky M., Harvey A., Jerusalinsky D. Peptide muscarinic toxins with agonist activity that preferentially bind to the m1 receptor subtype. Comunicaciones Biológicas. 13:1995;123-133.
36. Kornisiuk E., Jerusalinsky D., Cerveñansky C., Harvey A. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon. 33:1995;11-18.
37. Kornisiuk E., Cerveńansky C., Durán R., Alfaro P., Alonso M., Jerusalinsky D. New muscarinic toxin from D. viridis venom. Life Sci. 60:1997;1205.
38. Kornisiuk E., Alfaro P., Durán R., Rial Verde E., Cerveńansky C., Jerusalinsky D. Muscarinic receptor subtypes are clearly discriminated in the brain by muscarinic toxins. J. Neurochem. 73:1999;513.
39. Kubo T., Fukuda K., Mikami A., Maeda A., Takashashi H., Mishina M., Haya T., Haga K., Ichigama A., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;411-416.
40. Lazareno S., Buckley N., Roberts F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart and NG 108-15 cells. Molec Pharmacol. 38:1990;805-815.
41. Levey A. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 52:1993;441-443.
42. Liang J., Carsi-Gabrenas J., Krajewski J., McCafferty J., Purkerson S., Santiago M., Strauss W., Valentine H., Potter L. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon. 34:1996;1257-1267.
43. Max S., Liang J.S., Potter L.T. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci. 13:1993;4293-4300.
44. Max S., Liang J.S., Valentine H., Potter L. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J Pharmacol Exp Ther. 267:1993;480-485.
45. Nathanson N. Molecular properties of the muscarinic acetylcholine receptor. Ann Rev Neurosci. 10:1987;195-236.
46. Olianas M., Adem A., Karlsson E., Onali P. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Brit J Pharmacol. 118:1996;283-288.
47. Olianas M., Adem A., Karlsson E., Onali P. Differential effect of muscarinic toxin (MT3) on brain muscarinic receptors coupled to adenylyl cyclase. Life Sci. 60:1997;1206.
48. Olianas M., Adem A., Karlsson E., Onali P. Identification of rat brain muscarinic m4 receptor coupled to cyclic AMP using the selective muscarinic toxin 3. Eur. J. Pharmacol. 357:1998;235-242.
49. Paxinos G., Watson C. The Rat Stereotaxic Coordinates. 1986;Academic Press, San Diego.
50. Potter L., Krajewski J., Dickerson I. Cloning and expression of the cDNA for an m1-toxin. Life Sciences. 60:1996;1205.
51. Rodríguez-Ithurralde D., Silveira R., Barbeito L., Dajas F. Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom. Neurochem Int. 5:1983;267-274.
52. Rouse S.T., Gilmor M., Levey A. Differential presynaptic and postsynaptic expression of m1-m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse. Neuroscience. 86:1998;221-232.
53. Ségalas I., Thai R., Ménez R., Vita C. A particularly labile Asp-Pro bond in the green mamba muscarinic toxin MTX2. Effect of protein conformation on the rate of cleavage. FEBS Lett. 371:1995;171-175.
54. Vandermeers A., Vandermeers-Piret M., Rathe J., Waelbröeck M., Oras A., Karlsson E. Purification and sequence determination of a new muscarinic toxin (MT4) from the venom of the green mamba (Dendroaspis angusticeps). Toxicon. 33:1995;1171-1179.
55. Van Der Zee E., Luiten P.G. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localisation in relation to learning and memory. Progress in Neurobiology. 58:1999;409-471.
56. Wall S., Yasuda R., Hory F., Flagg S., Martin B., Ginns E., Wolfe B. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain. Mol Pharmacol. 39:1991;643-649.
57. Weiner N., Taylor P. Drugs acting at sinaptic and neuroeffector junctional sites. Gilman A., Goodman L., Rall T., Murad F. Goodman & Gilman's Pharmacological Basis of Therapeutics. 1985;66-235 MacMillan Ltd, New York.
58. Wolfman C., Da Cunha C., Jerusalinsky D., Levi de Stein M., Viola H., Izquierdo I., Medina J. Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection. Brain Res. 548:1991;74-80.
59. Yasuda R., Ciesla W., Flores L., Wall S., Li M., Satkus S., Weisstein J., Spagnola B., Wolfe B. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol. 43:1993;149-157.